ACE and myocardial infarction: Besides evidence that the remodeling process could be attenuated with early implementation of angiotensin-converting enzyme inhibitors (ACEi) after a myocardial infarction, the concept that a profoundly dilated ventricle in end-stage HF could revert to a significantly improved phenotype had not been reported [13,14].